Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?
Br J Dermatol
.
2022 Jun;186(6):1030-1032.
doi: 10.1111/bjd.21010.
Epub 2022 Apr 7.
Authors
Caitlin R Semsarian
1
,
Tara Ma
1
,
Brooke Nickel
1
,
Richard A Scolyer
2
3
4
,
Peter M Ferguson
2
3
4
,
H Peter Soyer
5
6
,
Lisa Parker
7
8
,
Alexandra Barratt
1
,
John F Thompson
2
3
9
,
Katy J L Bell
1
Affiliations
1
Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
2
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
3
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
4
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital & NSW Health Pathology, Camperdown, NSW, Australia.
5
The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, QLD, Woolloongabba, Australia.
6
Dermatology Department, Princess Alexandra Hospital, QLD, Woolloongabba, Australia.
7
Sydney School of Pharmacy, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
8
Department of Radiation Oncology, Royal North Shore Hospital, Sydney, NSW, Australia.
9
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
PMID:
35007335
PMCID:
PMC9546461
DOI:
10.1111/bjd.21010
No abstract available
MeSH terms
Dysplastic Nevus Syndrome* / diagnosis
Humans
Melanoma* / diagnosis
Skin Neoplasms* / diagnosis
Supplementary concepts
Melanoma, Cutaneous Malignant